Tysabri now used by 14000 for MS
RTE.ie - Ireland
14000 patients now use Elan and its partner Biogen's multiple sclerosis drug Tysabri around the world. The drug was taken off the market two years ago after ...
See all stories on this topic

LIFE DIGEST: House passes amendment giving ethical stem cell ...
BP News - Nashville,TN,USA
Among the afflictions treated successfully by non-embryonic stem cells are spinal cord injuries, rheumatoid arthritis, lupus, multiple sclerosis and sickle ...
See all stories on this topic

Aaronson steps down, but now away; Friedkin assumes stem cell chair
Boca Raton News - FL, USA
The embryonic stem cells come from fertility clinics. Infertile couples seeking to have a child through in vitro fertilization often have multiple embryos ...
See all stories on this topic

CHMP rejects Tysabri for Crohn's; groups appeal
Pharma Times (subscription) - London,UK
Elan and Biogen Idec are to appeal a decision by European regulators not to recommend approval of their embattled multiple sclerosis drug Tysabri for the ...
See all stories on this topic

Elan hit by Euro Tysabri decision
ShareCast - London,UK
LONDON (SHARECAST) - Pharmaceutical firm Elan turned lower Friday after it said the European Medicines Agency has refused to approve the use of its Tysabri ...
See all stories on this topic

Elan's Tysabri drug rejected by European Medicines Agency for ...
FinFacts Ireland - Ireland
An application for approval of Tysabri (natalizumab) for treatment of moderate to severe Crohn's disease was filed in the US on December 15, 2006. ...
See all stories on this topic

Earnings Preview: Biogen Idec
Forbes - NY,USA
OVERVIEW: The company entered the quarter off of strong growth for its two key drugs, Rituxan and Avonex, and its new multiple sclerosis drug Tysabri. ...
See all stories on this topic